A commercial quantity of a controlled drug under s 33(2) of the Controlled Substances Act 1984 (SA) can be established by the cumulative quantity produced across multiple batches, provided those batches form part of one process of manufacture. The characterisation of multiple batches as one or more processes of manufacture is a question of fact. The prosecution need not prove that a commercial quantity could be produced in a single batch.
The full text is available to signed-in members, including the 1 later case that cites this judgment.
1 of the 1 citing case carries a classified treatment. How each court treated it is available to signed-in members.